<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03856255</url>
  </required_header>
  <id_info>
    <org_study_id>18-02047</org_study_id>
    <nct_id>NCT03856255</nct_id>
  </id_info>
  <brief_title>Polyp Measurement Device</brief_title>
  <official_title>A Pilot, Single-centered, Single-arm, Feasibility Study Evaluating a Polyp Measurement Device in Patients Undergoing Screening or Surveillance Colonoscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NYU Langone Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>NYU Langone Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Colorectal cancer is the second-leading cause of cancer death in the United States.&#xD;
      Colorectal cancer screening is recommended to begin at age 50 years for most men and women at&#xD;
      average risk for this disease. Colonoscopy is a gold standard method of screening for&#xD;
      colorectal cancer, allowing for the detection and removal of colorectal polyps, some of which&#xD;
      can progress into malignancy. The literature has shown that the removal of polyps during a&#xD;
      colonoscopy results in decreased incidence and mortality related to colorectal cancer.&#xD;
      Indeed, the last decade has shown a decline in colorectal cancer incidence and mortality in&#xD;
      adults over age 50, largely due to increased colonoscopy screening. Currently, the risk of a&#xD;
      patient developing colorectal cancer and thus time intervals for colonoscopy surveillance&#xD;
      post-polypectomy is determined by the number, pathology, and size of the polyps that are&#xD;
      observed and removed during the colonoscopy procedure. Current surveillance guidelines&#xD;
      indicate the need for a shorter interval before the next colonoscopy for patients who have&#xD;
      one or more polyps that are 10mm or larger. In addition, different polypectomy techniques are&#xD;
      indicated for the treatment of polyps less than 20mm in size. For example, cold forceps may&#xD;
      be appropriate for removal of 1mm to 2mm polyps, cold snare for polyps less than 10mm, and&#xD;
      hot-snare resection for polyps 10mm to 19mm. Yet, while the number and pathology of polyps&#xD;
      are easily obtained and verified, it is standard practice for the size of a polyp to be&#xD;
      assessed through endoscopist optical visualization alone, without use of an objective device&#xD;
      or standard by which to measure it. Often, the endoscopist will compare the size of the polyp&#xD;
      to the size of the snare loop to estimate and document the size of the polyp(s). However,&#xD;
      with the size of a polyp being a major indicator of malignant potential as well as an&#xD;
      indicator of appropriate polypectomy technique and surveillance intervals, a device with&#xD;
      which to take and document accurate and objective measurements of polyps during colonoscopy&#xD;
      holds the potential for health benefits. In addition to having a potential clinical benefit&#xD;
      for each patient in terms of polypectomy and surveillance intervals, as an objective&#xD;
      indicator of polyp size, this technique also holds promise for use in future studies that&#xD;
      evaluate polyp size as an indicator of potential malignancy (or future malignancy) and for&#xD;
      use by national clinical guidelines committees who may utilize these objective data to update&#xD;
      future screening and surveillance recommendations.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Covid-19 restrictions with screening/surveillance colonoscopies&#xD;
  </why_stopped>
  <start_date type="Actual">June 24, 2019</start_date>
  <completion_date type="Actual">June 1, 2020</completion_date>
  <primary_completion_date type="Actual">June 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants Who Indicated Ease of Use in Advancing in Measuring Device Catheter Through the Working Channel</measure>
    <time_frame>At the time of the procedure</time_frame>
    <description>Scale of 1-10, with 1 being the easiest and 10 being the hardest</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean Score Indicating Ease of Extending and Retracting the Device</measure>
    <time_frame>At the time of of the procedure</time_frame>
    <description>Scale of 1-10, with 1 being the easiest and 10 being the hardest</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean Score Indicating Ease of Use in Placing the Measuring Device Adjacent to the Polyp in Order to Determine a Measurement</measure>
    <time_frame>At the time of the procedure</time_frame>
    <description>Scale of 1-10, with 1 being the easiest and 10 being the hardest</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean Score Indicating Ease of Use in Taking a Picture That Included the Measuring Device and Polyp in Order to Photo-document the Measurement Reading</measure>
    <time_frame>At the time of the procedure</time_frame>
    <description>Scale of 1-10, with 1 being the easiest and 10 being the hardest</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean Difference in Size of Polyp</measure>
    <time_frame>At the time of the procedure</time_frame>
    <description>The size of the polyp measured by the device will be subtracted from the size of the polyp as measured by the standard, device-free optical visualization.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">36</enrollment>
  <condition>Colorectal Cancer</condition>
  <arm_group>
    <arm_group_label>Micro-Tech Endoscopic Gauge</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Use of the device during screening or surveillance colonoscopy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Micro-Tech Endoscopic Gauge</intervention_name>
    <description>Use of Micro-Tech Endoscopic Gauge to measure any polyp detected during a screening or surveillance colonoscopy.</description>
    <arm_group_label>Micro-Tech Endoscopic Gauge</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Individuals age 50-85 years old, who require an outpatient screening or surveillance&#xD;
             colonoscopy&#xD;
&#xD;
          -  Ability to give consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Inflammatory bowel disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark Pochapin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>New York School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>New York University School of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>February 25, 2019</study_first_submitted>
  <study_first_submitted_qc>February 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 27, 2019</study_first_posted>
  <results_first_submitted>May 18, 2021</results_first_submitted>
  <results_first_submitted_qc>May 18, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">June 14, 2021</results_first_posted>
  <last_update_submitted>May 18, 2021</last_update_submitted>
  <last_update_submitted_qc>May 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>All of the individual participant data collected during the trial, after deidentification will be shared. Requests will be directed to mark.pochapin@nyulangone.org. To gain access, data requestors will need to sign a data access agreement.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>Data will become available beginning 3 months and ending 5 years following article publication</ipd_time_frame>
    <ipd_access_criteria>Researchers who provide a methodologically sound proposal will have access to the data.</ipd_access_criteria>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 21, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/55/NCT03856255/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Micro-Tech Endoscopic Gauge</title>
          <description>Use of the device during screening or surveillance colonoscopy&#xD;
Micro-Tech Endoscopic Gauge: Use of Micro-Tech Endoscopic Gauge to measure any polyp detected during a screening or surveillance colonoscopy.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Micro-Tech Endoscopic Gauge</title>
          <description>Use of the device during screening or surveillance colonoscopy&#xD;
Micro-Tech Endoscopic Gauge: Use of Micro-Tech Endoscopic Gauge to measure any polyp detected during a screening or surveillance colonoscopy.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="23"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63" lower_limit="50" upper_limit="85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants Who Indicated Ease of Use in Advancing in Measuring Device Catheter Through the Working Channel</title>
        <description>Scale of 1-10, with 1 being the easiest and 10 being the hardest</description>
        <time_frame>At the time of the procedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Micro-Tech Endoscopic Gauge</title>
            <description>Use of the device during screening or surveillance colonoscopy&#xD;
Micro-Tech Endoscopic Gauge: Use of Micro-Tech Endoscopic Gauge to measure any polyp detected during a screening or surveillance colonoscopy.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Indicated Ease of Use in Advancing in Measuring Device Catheter Through the Working Channel</title>
          <description>Scale of 1-10, with 1 being the easiest and 10 being the hardest</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Mean Score Indicating Ease of Extending and Retracting the Device</title>
        <description>Scale of 1-10, with 1 being the easiest and 10 being the hardest</description>
        <time_frame>At the time of of the procedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Micro-Tech Endoscopic Gauge</title>
            <description>Use of the device during screening or surveillance colonoscopy&#xD;
Micro-Tech Endoscopic Gauge: Use of Micro-Tech Endoscopic Gauge to measure any polyp detected during a screening or surveillance colonoscopy.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Score Indicating Ease of Extending and Retracting the Device</title>
          <description>Scale of 1-10, with 1 being the easiest and 10 being the hardest</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.43" spread="0.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Mean Score Indicating Ease of Use in Placing the Measuring Device Adjacent to the Polyp in Order to Determine a Measurement</title>
        <description>Scale of 1-10, with 1 being the easiest and 10 being the hardest</description>
        <time_frame>At the time of the procedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Micro-Tech Endoscopic Gauge</title>
            <description>Use of the device during screening or surveillance colonoscopy&#xD;
Micro-Tech Endoscopic Gauge: Use of Micro-Tech Endoscopic Gauge to measure any polyp detected during a screening or surveillance colonoscopy.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Score Indicating Ease of Use in Placing the Measuring Device Adjacent to the Polyp in Order to Determine a Measurement</title>
          <description>Scale of 1-10, with 1 being the easiest and 10 being the hardest</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.62" spread="0.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Mean Score Indicating Ease of Use in Taking a Picture That Included the Measuring Device and Polyp in Order to Photo-document the Measurement Reading</title>
        <description>Scale of 1-10, with 1 being the easiest and 10 being the hardest</description>
        <time_frame>At the time of the procedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Micro-Tech Endoscopic Gauge</title>
            <description>Use of the device during screening or surveillance colonoscopy&#xD;
Micro-Tech Endoscopic Gauge: Use of Micro-Tech Endoscopic Gauge to measure any polyp detected during a screening or surveillance colonoscopy.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Score Indicating Ease of Use in Taking a Picture That Included the Measuring Device and Polyp in Order to Photo-document the Measurement Reading</title>
          <description>Scale of 1-10, with 1 being the easiest and 10 being the hardest</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.17" spread="0.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Difference in Size of Polyp</title>
        <description>The size of the polyp measured by the device will be subtracted from the size of the polyp as measured by the standard, device-free optical visualization.</description>
        <time_frame>At the time of the procedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Micro-Tech Endoscopic Gauge</title>
            <description>Use of the device during screening or surveillance colonoscopy&#xD;
Micro-Tech Endoscopic Gauge: Use of Micro-Tech Endoscopic Gauge to measure any polyp detected during a screening or surveillance colonoscopy.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Difference in Size of Polyp</title>
          <description>The size of the polyp measured by the device will be subtracted from the size of the polyp as measured by the standard, device-free optical visualization.</description>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.28" spread="0.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>24 hours after procedure</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Micro-Tech Endoscopic Gauge</title>
          <description>Use of the device during screening or surveillance colonoscopy&#xD;
Micro-Tech Endoscopic Gauge: Use of Micro-Tech Endoscopic Gauge to measure any polyp detected during a screening or surveillance colonoscopy.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Mark Pochapin, MD</name_or_title>
      <organization>NYU Langone Health</organization>
      <phone>212-263-9177</phone>
      <email>Mark.Pochapin@nyulangone.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

